RESUMEN
OBJECTIVE: Data regarding opioid effects on esophageal function are limited. We previously demonstrated an association between chronic opioid use and esophageal motor dysfunction characterized by esophagogastric junction outflow obstruction, distal esophageal spasm, achalasia type III, and possibly Jackhammer esophagus. Our aim was to characterize the influence of different opioids and doses on esophageal dysfunction. METHODS: Retrospective review of 225 patients prescribed oxycodone, hydrocodone, or tramadol for >3 months, who completed high-resolution manometry from 2012 to 2017. Demographic and manometric data were extracted from a prospectively maintained motility database. Frequency of opioid-induced esophageal dysfunction (OIED, defined as distal esophageal spasm, esophagogastric junction outflow obstruction, achalasia type III, or Jackhammer esophagus on high-resolution manometry, was compared among different opioids. The total 24-hour opioid doses for oxycodone, hydrocodone, and tramadol were converted to a morphine equivalent for dose effect analysis. RESULTS: OIED was present in 24% (55 of 225) of opioid users. OIED was significantly more prevalent with oxycodone or hydrocodone use compared with tramadol (31% vs 28% vs 12%, P = 0.0162), and for oxycodone alone vs oxycodone with acetaminophen (43% vs 21%, P = 0.0482). There was no difference in OIED for patients taking hydrocodone alone vs hydrocodone with acetaminophen. Patients with OIED were taking a higher median 24-hour opioid dose than those without OIED (45 vs 30 mg, P = 0.058). DISCUSSION: OIED is more prevalent in patients taking oxycodone or hydrocodone compared with tramadol. There is greater likelihood of OIED developing with higher doses. Reducing the opioid dose or changing to tramadol may reduce OIED in opioid users.
Asunto(s)
Analgésicos Opioides/efectos adversos , Acalasia del Esófago/inducido químicamente , Espasmo Esofágico Difuso/inducido químicamente , Dolor Abdominal/tratamiento farmacológico , Adulto , Anciano , Analgésicos Opioides/administración & dosificación , Artralgia/tratamiento farmacológico , Dolor de Espalda/tratamiento farmacológico , Relación Dosis-Respuesta a Droga , Acalasia del Esófago/fisiopatología , Enfermedades del Esófago/inducido químicamente , Enfermedades del Esófago/fisiopatología , Espasmo Esofágico Difuso/fisiopatología , Unión Esofagogástrica/fisiopatología , Femenino , Humanos , Hidrocodona/administración & dosificación , Hidrocodona/efectos adversos , Masculino , Manometría , Persona de Mediana Edad , Oxicodona/administración & dosificación , Oxicodona/efectos adversos , Estudios Retrospectivos , Tramadol/administración & dosificación , Tramadol/efectos adversosAsunto(s)
Analgésicos Opioides/efectos adversos , Buprenorfina/efectos adversos , Espasmo Esofágico Difuso/inducido químicamente , Esfínter Esofágico Inferior/efectos de los fármacos , Analgésicos Opioides/administración & dosificación , Analgésicos Opioides/uso terapéutico , Buprenorfina/administración & dosificación , Buprenorfina/uso terapéutico , Trastornos de Deglución/etiología , Femenino , Humanos , Dolor de la Región Lumbar/tratamiento farmacológico , Manometría , Persona de Mediana Edad , Parche TransdérmicoAsunto(s)
Candidiasis Bucal/etiología , Cloranfenicol/efectos adversos , Esofagitis/etiología , Candida albicans/crecimiento & desarrollo , Candidiasis Bucal/complicaciones , Niño , Preescolar , Espasmo Esofágico Difuso/inducido químicamente , Espasmo Esofágico Difuso/complicaciones , Esofagitis/complicaciones , Esofagitis/microbiología , Humanos , Masculino , Combinación Trimetoprim y Sulfametoxazol/efectos adversosRESUMEN
A total of 394 patients with noncardiac chest pain underwent both basal esophageal manometry and combined esophageal motility and acid perfusion studies between 1986 and 1988. On basal esophageal manometry, 275 patients had a normal response, 64 patients had findings of high-amplitude peristalsis or "nut-cracker" esophagus, and 11 patients exhibited changes of diffuse esophageal spasm. Of the 275 patients who had normal findings on basal esophageal manometry, 90 patients (33%) had a positive response on combined esophageal motility and acid perfusion studies, that is, reproduction of chest pain with associated abnormal motility changes. The present study focuses on the 90 patients with acid-provoked esophageal spasm. On acid perfusion study, these 90 patients had a 46.2% rise in deglutition response and a 95% increase in duration compared with a 3.2% and a 4.3% change in values for the control group of healthy volunteers. Of the group with acid-induced spasm, 90.1% had excessive dysmotility changes (repetitive waves, multiple peaks, spontaneous or simultaneous contractions) compared with an incidence of 12.5% in the control group.